Realising the right to sexual and reproductive health: access to essential medicines for medical abortion as a core obligation

BACKGROUND: WHO has a pivotal role to play as the leading international agency promoting good practices in health and human rights. In 2005, mifepristone and misoprostol were added to WHO’s Model List of Essential Medicines for combined use to terminate unwanted pregnancies. However, these drugs wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Perehudoff, Katrina, Berro Pizzarossa, Lucía, Stekelenburg, Jelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796451/
https://www.ncbi.nlm.nih.gov/pubmed/29390996
http://dx.doi.org/10.1186/s12914-018-0140-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796451/
https://www.ncbi.nlm.nih.gov/pubmed/29390996
http://dx.doi.org/10.1186/s12914-018-0140-z

Ejemplares similares